Innoviva (INVA) Cost of Revenue: 2009-2024
Historic Cost of Revenue for Innoviva (INVA) over the last 6 years, with Dec 2024 value amounting to $36.6 million.
- Innoviva's Cost of Revenue rose 156.69% to $25.6 million in Q3 2025 from the same period last year, while for Sep 2025 it was $55.1 million, marking a year-over-year increase of 39.00%. This contributed to the annual value of $36.6 million for FY2024, which is 10.82% down from last year.
- According to the latest figures from FY2024, Innoviva's Cost of Revenue is $36.6 million, which was down 10.82% from $41.0 million recorded in FY2023.
- In the past 5 years, Innoviva's Cost of Revenue ranged from a high of $41.0 million in FY2023 and a low of $13.8 million during FY2022.
- For the 3-year period, Innoviva's Cost of Revenue averaged around $30.5 million, with its median value being $36.6 million (2024).
- As far as peak fluctuations go, Innoviva's Cost of Revenue skyrocketed by 197.54% in 2023, and later decreased by 10.82% in 2024.
- Yearly analysis of 3 years shows Innoviva's Cost of Revenue stood at $13.8 million in 2022, then skyrocketed by 197.54% to $41.0 million in 2023, then dropped by 10.82% to $36.6 million in 2024.